Fig. 1
From: Differential expression of ABCB5 in BRAF inhibitor-resistant melanoma cell lines
Discrepancy of sensitivity to PLX in different melanoma cell lines. a Schematic illustration of establishing PLX-resistant (PLXr) melanoma cell lines. Cell viability assay by MTT in melanoma cells (b) and PLX-resistant melanoma cells (c). Melanoma cells (b) and PLX-resistant melanoma cells (c) were treated for 72 h with different concentrations of PLX as indicated. Results are expressed as the percent of viable cells, and values represent the means ± SD (bars) of three independent experiments